Evolving therapeutic landscape in follicular lymphoma: a look at emerging and investigational therapies

Follicular Lymphoma (FL) is the most common subtype of indolent B cell non-Hodgkin lymphoma. The clinical course can be very heterogeneous with some patients being safely observed over many years without ever requiring treatment to other patients having more rapidly progressive disease requiring mul...

Descripción completa

Detalles Bibliográficos
Autores principales: Hanel, Walter, Epperla, Narendranath
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8247091/
https://www.ncbi.nlm.nih.gov/pubmed/34193230
http://dx.doi.org/10.1186/s13045-021-01113-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8247091/
https://www.ncbi.nlm.nih.gov/pubmed/34193230
http://dx.doi.org/10.1186/s13045-021-01113-2

Ejemplares similares